Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRioablation vs Antiarrhythmic Drugs for Persistent Atrial Fibrillation Trial (CRAFT)
2017-004202-18Phase 4Terminated
- Sponsor
- Fundación Interhospitalaria para la Investigación Cardiovascular
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amiodarone, disopyramide, propafenone, flecainide and dronabinol in Atrial fibrillation (AFib), atrial flutter (AFL) and atrial tachycardia (AT) (2 arms), sponsored by Fundación Interhospitalaria para la Investigación Cardiovascular. Primary endpoint: Atrial fibrillation recurrence. Started Jan 2018; status: terminated.
02
Drugs
amiodaronedisopyramidepropafenoneflecainidedronabinol
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)atrial tachycardia (AT)
Beyond the preview
Go deeper on 2017-004202-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004202-18.